Spruce Capital

Investor type

PE / VC

Founded

2013

AUM

-

Location

San Francisco, California, United States

Investment Ticket

$1-5 m

Investment Stage

Seed Series A Late Stage (Series C+)

Region of investment

North America South America

ESG Focus

Impact investor
Investor profile last updated: 23 July, 2026

Profile

Spruce Capital Partners is a life sciences investment firm based in the United States. It was founded by experienced investors known for their work and thought leadership in the life sciences industry. The team, consisting of managing partners who have collaborated for over a decade, specializes in fostering growth in companies that make positive environmental impacts and improve human health and wellness. Spruce Capital is distinguished by its combination of investment expertise and domain knowledge, assisting entrepreneurs in tackling global challenges.

The firm invests primarily in the life sciences sector with a focus on environmental impact and wellness. Specific areas of interest include biotechnology and healthcare services. While exact investment sizes aren't specified, the firm typically engages with seed and growth stages across various regions. Details about total AUM and additional fund specifics are not disclosed.

Notable investments made by Spruce Capital include Amfora - an agricultural biotech company, Provivi - focused on pest control, and Pivot Bio - which develops sustainable agriculture solutions. This select portfolio highlights Spruce Capital's commitment to pioneering ventures in life sciences that contribute positively to both environmental sustainability and human health.

Industry

Energy Infrastructure Life Sciences MedTech Robotics Pharmaceuticals Other Medical Devices Healthcare Services Foodtech Food and Beverage Biotechnology HealthTech

Contacts

Name
Title
Email
avatar
Roger Wyse Founder, Managing Partner
Founder, Managing Partner
-
avatar
Greg Young Managing Partner
Managing Partner
-
Upgrade to see contacts
avatar
LIcXADSU5okf1pqC LIcXADSU5okf1pqC
LIcXADSU5okf1pqC
avatar
LIcXADSU5okf1pqC LIcXADSU5okf1pqC
LIcXADSU5okf1pqC
avatar
LIcXADSU5okf1pqC LIcXADSU5okf1pqC
LIcXADSU5okf1pqC
Investment-team contacts for Spruce Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Spruce Capital

Spruce Capital is a venture capital and private equity firm. It backs companies at Seed, Series A and Late Stage (Series C+), writing tickets of $1-5 m.
Spruce Capital is located in San Francisco, California, United States.
Spruce Capital was founded in 2013.
Spruce Capital invests in companies and startups in Energy, Infrastructure, Life Sciences, MedTech, Robotics, Pharmaceuticals, Other, Medical Devices, Healthcare Services, Foodtech, Food and Beverage, Biotechnology, HealthTech.
Spruce Capital invests in companies and startups in North America, South America.
Spruce Capital invests in companies and startups at Seed, Series A, Late Stage (Series C+).
Spruce Capital usually invests $1-5 m on average.
Yes, Spruce Capital is impact investor.
Spruce Capital can be reached through its website sprucecp.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Spruce Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Spruce Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 23 July, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.